A HEAVY MAETAL CHELATE COMPOSITION CONTAINING CHITOSAN DERIVATIVES AND USES THEREOF

Details for Australian Patent Application No. 2003257771 (hide)

Owner SHANDONG MEILINYA BIO-TECH CO. LTD.

Inventors SONG, Xinrong; LI, Jianqing; MA, Rui; MEI, Zongfu; MA, Xinyun; REN, Qisheng

Pub. Number AU-A-2003257771

PCT Number PCT/CN03/00589

PCT Pub. Number WO2004/013219

Priority 02125605.5 24.07.02 CN

Filing date 23 July 2003

Wipo publication date 23 February 2004

International Classifications

C08L 005/08 Compositions of polysaccharides or of their derivatives not provided for in group or

C02F 001/62 Treatment of water, waste water, or sewage - Heavy metal compounds

C02F 011/14 Treatment of sludge - with addition of chemical agents

B09B 003/00 Destroying solid waste or transforming solid waste into something useful or harmless

B09C 001/02 Reclamation of contaminated soil

C09K 005/16 Heat-transfer, heat-exchange or heat-storage materials, e.g. refrigerants

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 02125605.5 24.07.02 CN

1 April 2004 Application Open to Public Inspection

  Published as AU-A-2003257771

19 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003257772-SILENT MUSICAL INSTRUMENT WITH AUDIO POWER AMPLIFIER CIRCUIT

2003257770-REPLICABILITY VIRUS WHICH CAN EXPRESS ANTI-TUMOUR ANTIBODY WITH HIGH EFFICIENCY AND THE USE OF IT